Liver tumor treatment study for large tumors
Part of Cancer, Digestive system clinical trials.
This study tests a targeted radiation treatment called Y90 for liver tumors that are too large for standard approaches. It aims to see how well the treatment works for people with primary or secondary liver cancers that mainly affect the liver and have at least one tumor bigger than 5 cm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- You have liver tumors that started in the liver or spread from elsewhere, with most of the disease in the liver
- You have at least one tumor that is larger than 5 cm
- Your remaining healthy liver is expected to be large enough (more than 40% of total liver or over 500 ml)
- You are healthy enough to have imaging tests like CT, MRI, and a special scan before and after treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests combining radiation therapy (radioembolization) with surgery to remove part of the liver for people with a single large liver tumor (over 8 cm) that hasn't spread. The goal is to see if this approach can treat the tumor effectively.
This trial tests a treatment called Y-90 radioembolization (SIRT) for people with liver cancer that is too large to be removed surgically. The treatment delivers tiny radioactive beads directly to the tumor through the liver's blood supply, which may shrink the tumor and improve outcomes.
This trial tests a targeted radiation treatment (Y-90 radioembolization) given before surgery for colorectal cancer that has spread to the liver. The goal is to shrink liver tumors enough to make them removable and improve the chance of a successful surgery.
This trial tests a treatment called yttrium-90 carbon microsphere radioembolization for people with liver cancer that has been previously treated. Tiny radioactive beads are delivered directly to the tumor through the blood vessels to destroy cancer cells from inside. This may be an option if your liver cancer has not spread beyond the liver and you can tolerate the procedure.
This study tests a special type of radiation therapy called Y-90 TARE (using radioactive beads delivered directly to liver tumors) to find the safest and most effective dose. It's for people with liver cancer or other liver tumors that cannot be removed by surgery.
This trial tests a radiation treatment called Y-90 given before liver surgery for colorectal cancer that has spread to the liver. The goal is to help the liver grow enough for safer, curative surgery, either right away or as part of a two-step operation.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.